Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Fu-Lan Yang"'
Publikováno v:
OncoTargets and therapy
Jun Ni, Yun Peng, Fu-Lan Yang, Xun Xi, Xing-Wei Huang, Chun He Department of Breast and Thyroid Surgery, People’s Hospital of Ganzhou City, Ganzhou, Jiangxi, People’s Republic of China Introduction: The aim of this study was to evaluate the expre
Autor:
Fu-lan Yang, Xi Zhou, Hanchun Chen, Junjiang Fu, Xinxing Wan, Fang-zhi Chen, Dianzheng Zhang, Mei-juan Zhou
Publikováno v:
BioMed Research International, Vol 2015 (2015)
BioMed Research International
BioMed Research International
Using the phage display biopanning technique, we have previously identified a heptapeptide KLWVIPQ which specifically binds to the surface of the IFN-α-sensitive but not the IFN-α-resistant CML cells. The effects of this heptapeptide on the IFN-α-
Publikováno v:
Oncology Letters; Nov2020, Vol. 20 Issue 5, p1-7, 7p
Autor:
Ai-hua Xu, Xinxing Wan, Xing Huang, Mei-juan Zhou, Dianzheng Zhang, Fang-dan Ou-yang, Qian Fang, Fu-lan Yang, Hanchun Chen, Md. Asaduzzaman Khan, Feng-mao Huang
Publikováno v:
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 34(5)
Lung adenocarcinoma (ADC) is one of the major histological types of lung cancer. Genetic polymorphism in DNA repair genes and lung ADC susceptibility is well documented. In this case–control study, the association between the polymorphic sites of D
Autor:
Fang-dan Ou-yang, Hanchun Chen, Xinxing Wan, Feng-mao Huang, Fu-lan Yang, Dianzheng Zhang, Ai-hua Xu, Md. Asaduzzaman Khan
Publikováno v:
Medical Oncology. 30
Lung cancer is a common cause of cancer-related death. The link between risk of lung cancer susceptibility and genetic polymorphisms in metabolic enzymes is well documented. In this study, the relationships between lung cancer susceptibility and poly
Autor:
Fu-lan Yang, Ai-hua Xu, Yun-yi Zhang, Dianzheng Zhang, Md. Asaduzzaman Khan, Xinxing Wan, Hanchun Chen
Publikováno v:
BioMed Research International, Vol 2013 (2013)
BioMed Research International
BioMed Research International
Hepatocellular carcinoma (HCC) is one of the most prevalent tumors worldwide. Interferon-α(IFN-α) has been widely used in the treatment of HCC, but patients eventually develop resistance. ISG15 ubiquitin-like modifier (ISG15) is a ubiquitin-like pr
Autor:
Xin-xing Wan, Han-chun Chen, Khan, Md. Asaduzzaman, Ai-hua Xu, Fu-lan Yang, Yun-yi Zhang, Dian-zheng Zhang
Publikováno v:
BioMed Research International; 2013, Vol. 2013, p1-8, 8p